The evaluation of a rapid microfluidic immunofluorescence antigen test in detecting the infectiousness of COVID-19 patients

[1]  G. Rubin,et al.  Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial , 2022, The Lancet Respiratory Medicine.

[2]  L. Hooft,et al.  Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection , 2022, The Cochrane database of systematic reviews.

[3]  Ö. Ergönül,et al.  Duration of infectious shedding of SARS-CoV-2 Omicron variant and its relation with symptoms , 2022, Clinical Microbiology and Infection.

[4]  M. Siedner,et al.  Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection , 2022, The New England journal of medicine.

[5]  A. Cohen,et al.  A nationwide analytical and clinical evaluation of 44 rapid antigen tests for SARS-CoV-2 compared to RT-qPCR , 2022, Journal of Clinical Virology.

[6]  Kaitlin F. Mitchell,et al.  Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection. , 2022, JAMA internal medicine.

[7]  T. Kanno,et al.  Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees , 2022, Emerging infectious diseases.

[8]  J. Tate,et al.  Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures , 2022, Emerging infectious diseases.

[9]  R. Arnaout,et al.  Sars-Cov-2 antigen tests predict infectivity based on viral culture: comparison of antigen, PCR viral load, and viral culture testing on a large sample cohort , 2021, Clinical Microbiology and Infection.

[10]  M. Rugeles,et al.  The Usefulness of Antigen Testing in Predicting Contagiousness in COVID-19 , 2021, medRxiv.

[11]  J. Vandesompele,et al.  The dangers of using Cq to quantify nucleic acid in biological samples; a lesson from COVID-19. , 2021, Clinical chemistry.

[12]  T. Nabeshima,et al.  Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling , 2021, Journal of Infection and Chemotherapy.

[13]  A. Pandey,et al.  Analytical sensitivity and specificity of four point of care rapid antigen diagnostic tests for SARS-CoV-2 using real-time quantitative PCR, quantitative droplet digital PCR, and a mass spectrometric antigen assay as comparator methods. , 2021, Clinical chemistry.

[14]  L. Gieselmann,et al.  Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals , 2021, Journal of clinical microbiology.

[15]  T. Trenti,et al.  Estimate false‐negative RT‐PCR rates for SARS‐CoV‐2. A systematic review and meta‐analysis , 2021, European journal of clinical investigation.

[16]  D. McManus,et al.  Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection , 2021, medRxiv.

[17]  R. Bartenschlager,et al.  Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2 , 2021, Infection.

[18]  Charles K. Cooper,et al.  Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  E. Fischer,et al.  Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer , 2020, Cell.

[20]  A. van Belkum,et al.  Considerations for diagnostic COVID-19 tests , 2020, Nature reviews. Microbiology.

[21]  Daniel B Larremore,et al.  Rethinking Covid-19 Test Sensitivity - A Strategy for Containment. , 2020, The New England journal of medicine.

[22]  A. Charlett,et al.  Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[23]  P. V. Van Caeseele,et al.  Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples , 2020, Clinical Infectious Diseases.

[24]  Zachary Schiffman,et al.  Predicting infectious SARS-CoV-2 from diagnostic samples , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  M. Mina,et al.  To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[27]  Sheng Zhang,et al.  Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Center for Disease Control and Prevention Classification System for HIV-Infected Adults and Adolescents Clinical Classification , 2020, Definitions.